Gilles Paintaud Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2019	Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study.
4/2012	Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma.
10/2009	Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma.
4/2007	Pharmacokinetics of rituximab and its clinical use: thought for the best use?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Paintaud Research Topics

Disease

15	Rheumatoid Arthritis 01/2022 - 01/2009
14	Crohn Disease (Crohn's Disease) 01/2022 - 01/2006
14	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 10/2009
12	Neoplasms (Cancer) 01/2022 - 07/2004
8	Breast Neoplasms (Breast Cancer) 10/2021 - 12/2014
6	Ankylosing Spondylitis 01/2022 - 06/2011
5	Necrosis 01/2022 - 01/2012
4	Lymphoma (Lymphomas) 01/2019 - 04/2009
4	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 04/2007
4	Inflammation (Inflammations) 01/2017 - 06/2011
4	Hereditary Hemorrhagic Telangiectasia 01/2015 - 02/2012
4	Epistaxis (Nosebleed) 01/2015 - 02/2012
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2017
3	Infections 01/2022 - 04/2008
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 11/2017
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 01/2020
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 04/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021 - 08/2008
2	Exanthema (Rash) 10/2021 - 11/2020
2	Meningeal Carcinomatosis 01/2021 - 01/2018
2	Infarction (Infarctions) 12/2020 - 01/2017
2	ST Elevation Myocardial Infarction 12/2020 - 01/2017
2	Rheumatic Diseases (Rheumatism) 01/2017 - 06/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016 - 10/2009
1	Chronic Hepatitis B 01/2022
1	Mucositis 10/2021
1	Hemorrhage 04/2021
1	Retinal Diseases 04/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Axial Spondyloarthritis 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2019
1	Hemolysis 01/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019
1	Leukemia 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Vomiting 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Nausea 01/2018
1	Pathologic Neovascularization 01/2018
1	Cardiotoxicity 01/2018
1	Neck Pain (Cervicalgia) 01/2018
1	Headache (Headaches) 01/2018
1	Leukopenia 01/2017

Drug/Important Bio-Agent (IBA)

26	Monoclonal AntibodiesIBA 01/2022 - 04/2007
23	Infliximab (Remicade)FDA Link 01/2022 - 01/2006
15	Rituximab (Mabthera)FDA Link 01/2022 - 07/2004
10	Bevacizumab (Avastin)FDA Link 11/2020 - 03/2010
9	Cetuximab (Erbitux)FDA Link 01/2021 - 09/2008
8	Trastuzumab (Herceptin)FDA Link 10/2021 - 12/2014
7	Pharmaceutical PreparationsIBA 11/2021 - 01/2009
7	Adalimumab (Humira)FDA Link 01/2020 - 11/2009
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2011
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021 - 01/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 12/2007
4	Immunoglobulin G (IgG)IBA 06/2021 - 07/2004
4	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2011
4	AntibodiesIBA 01/2020 - 06/2011
2	Biological ProductsIBA 10/2021 - 01/2006
2	RamucirumabIBA 04/2021 - 01/2018
2	Panitumumab (Vectibix)FDA Link 01/2021 - 02/2018
2	Troponin IIBA 12/2020 - 01/2017
2	Creatine Kinase (Creatine Phosphokinase)IBA 12/2020 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2020 - 10/2009
2	Docetaxel (Taxotere)FDA Link 11/2020 - 12/2014
2	C-Reactive ProteinIBA 12/2018 - 01/2006
2	Carcinoembryonic AntigenIBA 01/2018 - 11/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 10/2011
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 10/2011
2	AerosolsIBA 01/2014 - 09/2011
1	Tenofovir (Viread)FDA Link 01/2022
1	AntigensIBA 01/2022
1	Everolimus FDA Link 10/2021
1	TOR Serine-Threonine KinasesIBA 10/2021
1	eculizumab FDA Link 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 11/2020
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	CytokinesIBA 11/2020
1	Interleukin-23 (Interleukin 23)IBA 11/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 04/2019
1	Calcium Channels (Calcium Channel)IBA 04/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Inosine Triphosphate (ITP)IBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	Rho(D) Immune Globulin (RhoGAM)IBA 01/2019
1	Drug CombinationsIBA 01/2019
1	RHO(D) antibody (anti-D)IBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	GlucocorticoidsIBA 01/2017

Therapy/Procedure

10	Therapeutics 11/2020 - 06/2008
4	Drug Therapy (Chemotherapy) 01/2019 - 04/2007
2	Aftercare (After-Treatment) 01/2022 - 01/2006
1	Intravenous Administration 01/2021
1	Injections 01/2019
1	Drug Administration Schedule 01/2018